The question bank is the fastest way to start, but PMHNP Helper also includes board-review planning, student resources, and plain-English guidance for psychiatric nurse practitioner students who are still learning the exam landscape.
A 22-year-old college student presents with a confirmed history of attention-deficit/hyperactivity disorder diagnosed in childhood and a new onset of major depressive disorder over the past four months. His ADHD was previously managed with a stimulant medication that was discontinued two years ago when he felt he no longer needed it. He now reports worsening inattention, poor concentration, low motivation, depressed mood, anhedonia, and sleep disturbance. His PHQ-9 score is 16 and his Adult ADHD Self-Report Scale score is elevated. He has no history of mania, hypomania, substance use disorder, or psychosis. Which of the following best describes the appropriate treatment-planning approach for this patient?
Explanation
Comorbid ADHD and major depressive disorder require treatment planning that addresses both conditions, typically prioritizing the more acutely impairing condition. Sequential medication introduction is often preferred to allow clear assessment of each agent's effects. Ongoing monitoring is essential to distinguish overlapping symptoms and optimize treatment for each condition.
Key Takeaway
When ADHD and MDD co-occur, treatment should address both conditions with priority given to the more acute presentation, using sequential medication introduction when possible to allow clear attribution of treatment responses and side effects.